ArcheMedX is heading west January 12th-15th for the 38th Annual JP Morgan Healthcare Conference. Let’s connect in San Francisco to explore how behavioral science and actionable insights can improve clinical trial readiness and commercial success.
Please contact our team to coordinate a specific time to meet during the conference and / or at the Virginia Reception on January 12th.
Join ArcheMedX, CvilleBioHub, and Virginia Bio to foster connections at the Virginia Reception during JP Morgan Week
Virginia-based companies are invited to a private Virginia Reception hosted by VirginiaBio and CvilleBioHub on January 12, 2020, the eve of JP Morgan Healthcare week, at the elegant Velvet Room in the Clift Hotel, just off Union Square.
Sunday, January 12th 5-7pm at The Clift Royal Sonesta Hotel
Kelly Ritch’s addition better equips ArcheMedX to scale the capabilities it provides to transform clinical operations.
Charlottesville, VA (PRWEB) November 14, 2019
ArcheMedX, the company improving clinical trial readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform, with sponsors and CROs, ArcheMedX has appointed Kelly Ritch as Vice President of Clinical Research Solutions. Kelly will apply her 20 years of clinical operations experience to accelerate growth of the company’s clinical research business.
“As the complexity and cost of clinical research increases, a key to reducing the risk of under-performing trials is ensuring the preparedness of staff and sites” said Ms. Ritch. She added, “I’m excited to join the ArcheMedX team and help clinical operations leaders make faster, more informed decisions that improve trial efficiency and outcomes.”
Kelly is a dynamic and innovative executive adept at driving high-performance and long-term value through the applied use of software, data, and technology driven solutions for clinical research. Her operational expertise and strategic mindset will enable ArcheMedX to scale the capabilities it provides to a growing customer base.
Nearly every clinical trial encounters operational challenges and according to industry reports 86% of trials experience a study startup delay and 72% of studies run more than one month behind schedule. These delays can have significant financial costs for each day that a trial impedes a product’s development and launch.
At ArcheMedX, we arm trial stakeholders with more than an advanced training solution — we provide the early warning detection they need to mitigate operational risk and reduce costly delays,” said ArcheMedX CEO and co-founder Joel Selzer. “This is a pivotal time for the clinical research sector, and we are thrilled to have an industry leader with Kelly’s breadth of experience join the team. With Kelly’s appointment we are better equipped to expand the product and commercial strategies at ArcheMedX that will transform clinical operations.”
Kelly has previously led clinical data management, sales and marketing, clinical trial operations, and strategic partnerships with both sponsors and CROs. While creating and leading high-performance teams across clinical research functions, Kelly has had the opportunity to evaluate, implement, and develop a number of key software platforms used to support and improve clinical trial performance. Kelly has earned degrees from University of Virginia, University of North Carolina Chapel Hill, and University of Virginia Darden School of Business.
ArcheMedX applies behavioral science to transform learning and generate actionable insights across the life sciences and healthcare industries. Ready, the company’s clinical trial readiness platform, enables clinical research leaders to evaluate and improve the preparedness of project teams and site personnel and serves as an early warning detection system to reduce the risks and costs associated with under-performing clinical trials. To learn more about our operational intelligence and workforce readiness solutions visit www.archemedx.com or follow ArcheMedX on LinkedIn.
Our co-founder and CEO Joel Selzer will be speaking at MAGI’s Clinical Research Conference – 2019 West in Las Vegas October 27-30. Join Joel at the Innovations in Training session Tuesday the 29th at 2:45pm to explore how more tailored training and operational insights can help sponsors and CROs avoid the all too common training misadventure.
Here’s the introduction and the full interview can be found below. Enjoy!
“Clinical trials often encounter operational challenges and sponsors and CROs seek effective site-readiness practices. In this interview, Joel B. Selzer, co-founder and CEO, ArcheMedX, Inc., discusses the impact that healthcare technology has on clinical trials, focusing on the development of the company’s workforce readiness platform.”
During the Meeting, I was invited to join PharmaVoice to discuss how Ready analyzes behavioral data to enable Sponsors, CROs, and other trial stakeholders to evaluate and improve the readiness of their workforce and sites.
The video below includes highlights from our discussion.
If you are interested in learning more about Ready and how ArcheMedX is mitigating trial risk, please contact our team to schedule a capabilities presentation or demo.
Thank you again to Taren Grom and the PharmaVoice team for sharing this interview.
Since this is will be our first time exhibiting at DIA, we reached out to our friends and colleagues at various Sponsors, CROs, and other trial stakeholders for a little advice on how to ensure we would be ready. Here’s what they shared.
1. Wear comfortable shoes and if your activities for the day require nicer footwear, bring comfortable shoes along anyway. If necessary, the convention first aid room always has blister band aids.
2. Bring a water bottle. There are multiple fill-up spots and staying hydrated is the way to go.
3. Share power with your peers. Bring a multi-device charging plug and share power-up spots whenever possible.
4. Try to set aside a little time before the end of each day to reflect and summarize your notes, discussions, and experiences. The days are fast and full and taking a few minutes can help make sure more of that information makes the trip home and positively impacts your work.
5. Set daily goals. For example, I will attend two sessions, demo 3 new platforms, and talk to 2 new service providers. The volume of sessions and sheer size of the exhibition hall can make it hard to feel productive. A plan and goals to keep the day on track can be helpful.
Are You Ready for DIA 2019? San Diego has long been known for beaches, beer, and fish tacos, but now top quality restaurants are popping up across the city. Here are five of the best places to eat and drink during DIA 2019!
1. Tin Fish: Step right out the front doors of the Convention Center for some quick fish tacos
2. Nason’s Beer Hall: If you have a big group looking to unwind, this beer garden has plenty of space and lots of fun games for your team to blow off some steam
3. Seasons 52: Enjoy seasonal American fare, an extensive wine list, and a chance to explore Seaport Village
4. Herb and Wood: Little Italy is a happening area and this award-winning restaurant by celebrity Chef Brian Malarkey relies on high quality ingredients and their wood fire oven
5. Juniper & Ivy: Use that expense account and get your Top Chef fix with this modern American restaurant led by All-Stars winner Richard Blais
Consider a short walk to Embarcadero Marina Park South. This waterfront public park features fishing piers, bike paths, basketball courts & a concession stand. Less than a half mile walk from the convention center via the Grand Stairway.
If you are in search of more innovative approaches to mitigating clinical trial risk, then don’t miss your chance to explore the Innovators Hub at DIA. Swing by the ArcheMedX booth (#2101) to see Ready in action (schedule a demo) and be entered to win a customized set of Away luggage (~$500 value).
ArcheMedx, which provides tech solutions for life sciences and healthcare, has launched a new digital service that aims to cut risks and costs associated with under-performing clinical trials.
The company will unveil the tool called Ready at this year’s Drug Information Association (DIA) annual meeting, which takes place in San Diego later this month.
According to the company based in Charlottesville, Virginia, the tool enables those running trials to evaluate and improve the preparedness of project teams and site personnel.
The tool analyses the behaviour of each participant as they engage in personalised learning experiences.
Insights delivered by the platform serve as an early warning detection system to identify risks sooner, ensure resources are more effectively deployed, and enhance staff and site performance.
Joel Selzer, CEO of ArcheMedX, said: “As the complexity and cost of clinical research increases, a key to reducing the risk of under-performing trials is ensuring the preparedness of staff and sites.”
“Ready arms clinical operation leaders with a powerful new tool to take action and mitigate trial risk and DIA is the perfect event to unveil its capabilities and expand our understanding of how the platform can better support contract research organisations (CROs), sponsors, and other trial stakeholders.”
In late 2017 the company said it closed $2.5 million in equity financing by early stage investors Jaffray Woodriff and Greyson Williams.
Earlier this week, the American Society of Clinical Oncology (ASCO) warned that trials are being held back by outdated and outmoded recruitment eligibility criteria.
A study showed that relaxing three rules used to screen patients almost doubled the number of patients on a dummy lung cancer trial.
The research looked at the health records of 10,500 patients from 2011 to 2018 with advanced non-small cell lung cancer on ASCO’s cancer database.
New criteria would allow for brain metastases, previous or current cancer diagnoses, and creatine clearance levels as low as 30 millilitres per minute, which can indicate kidney damage or impaired function.